Compare IRM & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRM | IQV |
|---|---|---|
| Founded | 1951 | 1982 |
| Country | United States | United States |
| Employees | N/A | 93000 |
| Industry | Real Estate Investment Trusts | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.0B | 28.6B |
| IPO Year | 1997 | 2013 |
| Metric | IRM | IQV |
|---|---|---|
| Price | $126.76 | $156.99 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 16 |
| Target Price | $122.50 | ★ $227.13 |
| AVG Volume (30 Days) | ★ 1.4M | 1.3M |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.02% | N/A |
| EPS Growth | N/A | ★ 4.67 |
| EPS | 0.48 | ★ 7.84 |
| Revenue | $4,491,531,000.00 | ★ $9,739,000,000.00 |
| Revenue This Year | $13.30 | $6.77 |
| Revenue Next Year | $9.31 | $5.89 |
| P/E Ratio | $256.06 | ★ $20.30 |
| Revenue Growth | 8.30 | ★ 41.60 |
| 52 Week Low | $77.77 | $134.65 |
| 52 Week High | $126.43 | $247.05 |
| Indicator | IRM | IQV |
|---|---|---|
| Relative Strength Index (RSI) | 74.16 | 35.92 |
| Support Level | $98.60 | N/A |
| Resistance Level | N/A | $193.26 |
| Average True Range (ATR) | 3.48 | 5.68 |
| MACD | 0.84 | -1.59 |
| Stochastic Oscillator | 97.56 | 7.16 |
Iron Mountain Inc is an information management services provider organized and operated as a real estate investment trust. The company offers solutions to its clients to address their information management, digital transformation, information security, data center, and asset lifecycle management (ALM) needs. Its customers come from various industries, including commercial, legal, financial, healthcare, technology, etc. The company has two reportable segments: Global Records and Information Management (Global RIM) and Global Data Center. Maximum revenue is generated from the Global RIM segment, which offers data and records management, secure shredding, consumer storage, and other related services. Geographically, the company generates maximum revenue from the United States.
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its reserach and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.